Accutane Generics Need Separate Risk Management Programs, Roche Says

FDA should require that generic isotretinoin applicants implement their own pregnancy prevention programs instead of incorporating the generics into Roche's Accutane risk management program, Roche argued in a Feb. 5 citizen petition